Screening | German Center for Infection Research

Short description

Screening is a systematic testing method with the aim of identifying elements with certain properties.

Detailed description

A screening of humans is mostly done to detect diseases early. So-called natural compound libraries can be screened, too, in order to find a natural product with desired properties. These products can, for example, be further developed into a drug.

Apr 2024

Int J Tuberc Lung Dis

Screening of refugees from Ukraine for TB: a TBnet survey

Autoren

Argel M et al.

Dec 2023

New Microbes New Infect

Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant Klebsiella pneumoniae to identify potent inhibitory compounds

Autoren

Sivasankar S et al.

Jan 2024

Cells

Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation

Autoren

Staffeldt L et al.

Feb 2024

Vaccines (Basel)

High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5

Autoren

Wettengel JM et al.

Nov 2023

Eur Respir J

Tuberculosis screening in migrants to the EU/EEA and UK

Autoren

Köhler N et al.

Nov 2023

J Hepatol

Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany

Autoren

Hüppe D

Wedemeyer H

Cornberg M

Oct 2023

Int J Cancer

A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening

Autoren

Fan XH et al.

Prof. Dr. Anna Hirsch und Dr. Walid A. M. Elagher

Breathing easy thanks to new antibiotics

New active substances for the treatment of resistant bacteria are needed more urgently than ever – yet only few candidates make the leap from research to clinical application. To facilitate precisely

Developing novel strategies against tuberculosis and malaria

Tuberculosis and malaria are among the deadliest infectious diseases worldwide and are increasingly spreading, not least due to climate change. In both cases, antimicrobial resistance renders

Research Center Borstel, Leibniz Lung Center

Researching lung damage, immunology, and treatment needs as sub-studies in the household cohort study ERASE-TB

With ten million cases and 1.4 million deaths in 2021 alone, Mycobacterium tuberculosis remains one of the world's most dangerous pathogens. Early diagnosis of the disease and tracking of people at increased risk of developing TB are critical to minimising infection and containing TB. The ongoing ...